HK1192231A1 - Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use thereof -iv i - Google Patents
Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use thereof -iv iInfo
- Publication number
- HK1192231A1 HK1192231A1 HK14105514.0A HK14105514A HK1192231A1 HK 1192231 A1 HK1192231 A1 HK 1192231A1 HK 14105514 A HK14105514 A HK 14105514A HK 1192231 A1 HK1192231 A1 HK 1192231A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitor
- salt
- preparation
- crystal form
- dipeptidyl peptidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110202157 | 2011-07-09 | ||
PCT/CN2012/078294 WO2013007167A1 (zh) | 2011-07-09 | 2012-07-06 | 二肽基肽酶-iv抑制剂的盐的晶型i及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1192231A1 true HK1192231A1 (en) | 2014-08-15 |
Family
ID=47442601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14105514.0A HK1192231A1 (en) | 2011-07-09 | 2014-06-11 | Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use thereof -iv i |
Country Status (7)
Country | Link |
---|---|
US (1) | US8927572B2 (xx) |
EP (1) | EP2730575B1 (xx) |
JP (1) | JP5695800B2 (xx) |
CN (1) | CN102863440B (xx) |
ES (1) | ES2547687T3 (xx) |
HK (1) | HK1192231A1 (xx) |
WO (1) | WO2013007167A1 (xx) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017107945A1 (zh) * | 2015-12-24 | 2017-06-29 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv抑制剂的苯甲酸盐的晶型 |
WO2017211293A1 (zh) * | 2016-06-08 | 2017-12-14 | 山东轩竹医药科技有限公司 | 二肽基肽酶-iv抑制剂的丁二酸盐的晶型 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UY28103A1 (es) * | 2002-12-03 | 2004-06-30 | Boehringer Ingelheim Pharma | Nuevas imidazo-piridinonas sustituidas, su preparación y su empleo como medicacmentos |
EP1568699A4 (en) * | 2002-12-04 | 2007-08-15 | Eisai R&D Man Co Ltd | 1,3-DIHYDROIMIDAZOLE CONNECTION WITH CONDENSED RING |
CN101228164A (zh) * | 2005-05-20 | 2008-07-23 | 布里斯托尔-迈尔斯·斯奎布公司 | 二肽基肽酶iv的吡咯并吡啶类抑制剂及方法 |
US7521557B2 (en) * | 2005-05-20 | 2009-04-21 | Bristol-Myers Squibb Company | Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods |
US7989469B2 (en) * | 2008-02-04 | 2011-08-02 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
AR074072A1 (es) * | 2008-11-11 | 2010-12-22 | Lilly Co Eli | Compuesto de imidazol -piperidin -pirrol-pirimidin-6-ona, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar el glioblastoma multiforme |
CN102127070A (zh) * | 2010-01-15 | 2011-07-20 | 山东轩竹医药科技有限公司 | 吡啶并环衍生物 |
-
2012
- 2012-07-06 WO PCT/CN2012/078294 patent/WO2013007167A1/zh active Application Filing
- 2012-07-06 JP JP2014517432A patent/JP5695800B2/ja not_active Expired - Fee Related
- 2012-07-06 ES ES12812010.2T patent/ES2547687T3/es active Active
- 2012-07-06 US US14/127,824 patent/US8927572B2/en active Active
- 2012-07-06 EP EP12812010.2A patent/EP2730575B1/en not_active Not-in-force
- 2012-07-08 CN CN201210251941.3A patent/CN102863440B/zh active Active
-
2014
- 2014-06-11 HK HK14105514.0A patent/HK1192231A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP2730575B1 (en) | 2015-09-16 |
CN102863440B (zh) | 2015-05-27 |
US8927572B2 (en) | 2015-01-06 |
US20140206874A1 (en) | 2014-07-24 |
JP5695800B2 (ja) | 2015-04-08 |
ES2547687T3 (es) | 2015-10-08 |
EP2730575A1 (en) | 2014-05-14 |
CN102863440A (zh) | 2013-01-09 |
WO2013007167A1 (zh) | 2013-01-17 |
JP2014520763A (ja) | 2014-08-25 |
EP2730575A4 (en) | 2014-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2726075A4 (en) | NEW CRYSTALLINE FORMS OF A DIPEPTIDYL-PEPTIDASE IV HEMMER | |
PL2863918T3 (pl) | Kryształy soli inhibitora pde1 | |
HK1174114A1 (en) | Representation of people in a spreadsheet | |
ZA201308065B (en) | Combinations of akt inhibitor compounds and vemurafenib and methods of use | |
ZA201303433B (en) | Inhibitors of hiv replication | |
EP2748407A4 (en) | BACKGROUND TOOL AND METHOD OF USE | |
ZA201401653B (en) | Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use | |
IL270748B (en) | Preparations containing a substance with anticoxinic activity and their use to increase the activity of acetylcholinesterase inhibitors | |
EP2709993A4 (en) | AMORPHIC MIRABEGRON AND METHOD FOR CRYSTALLINE FORMS OF MIRABEGRON | |
HK1202628A1 (en) | Methods and compositions for determining responsiveness to treatment with a tnf-alpha inhibitor tnf- | |
EP2697422A4 (en) | COMPOSITION AND METHOD FOR PRODUCING A SELF-DECONTAMINATING SURFACE | |
HK1201524A1 (zh) | 激酶抑制劑及治療相關疾病的方法 | |
EP2743261A4 (en) | 4-HYDROXY-2-OXO-1-PYRROLIDINACETAMIDE RACEMAT CRYSTAL FORM I AND MANUFACTURING METHOD THEREFOR | |
GB201101810D0 (en) | A method of connecting meshes | |
EP2844271A4 (en) | PROCESSING METHOD AND AGENTS USEFUL THEREFOR | |
WO2012145254A9 (en) | Methods of using inhibitors of rorϒt to treat disease | |
PL2760271T3 (pl) | Prasa do bel i sposób czyszczenia prasy do bel | |
EP2709999A4 (en) | QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE | |
SG10201405403QA (en) | Novel salts of dpp-iv inhibitor | |
EP2717869A4 (en) | TREATMENT PROCEDURE WITH A BCAT1 HEMMER | |
HK1176675A1 (zh) | 形成用於裝置中的增強表面壁的方法 | |
EP2663574A4 (en) | RETRO VIRUS REPLICATION INHIBITORS | |
HK1192231A1 (en) | Crystal form i of salt of a dipeptidyl peptidase-iv inhibitor and preparation method and use thereof -iv i | |
EP2729468A4 (en) | TRICYCLIC HETEROCYCLES AS DIPEPTIDYLPEPTIDASE IV INHIBITORS | |
EP2681199A4 (en) | (-) - HUPERZIN-A METHOD AND COMPOSITIONS THEREFOR AND TREATMENT PROCESS THEREFOR |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20190704 |